Concordantly, USP22high-BLBC and -HER2+-BC patients that showed a pronounced CSC signature (Fig. 2B-C) and poor survival outcome (Fig. 2D) display a concomitant enrichment for gene sets of the mitochondrial transcriptomic program (Fig. 4E, top panel). Here, ERBB2 is linked to breast cancer.